Boeing Company (The) (BA)

Key Updates

Boeing shares have extended their rebound, rising 2.41% to $232.00 since the prior report, building on a 6.33% advance earlier in the session as the market continues to reward operational stabilization. The 1-day gain of 7.34% and 5-day rally of 9.69% reflect sustained buying momentum following the company's dominant Farnborough Airshow performance and Q2 earnings that demonstrated positive free cash flow and record backlog. The investment thesis remains centered on execution risk as the company transitions from cash burn to sustainable profitability under CEO Kelly Ortberg's turnaround.

Current Trend

Boeing's stock is exhibiting near-term strength with a 5-day gain of 9.69% and a 1-month advance of 2.43%, though the 6-month performance remains essentially flat at -0.49%. Year-to-date, the shares are up 6.85%, recovering from deeper trailing-twelve-month declines of approximately 8%. The current price action suggests the stock is testing higher resistance levels after consolidating around $213–$227, with the recent breakout above $230 establishing a new near-term support floor. The sharp 1-day move of 7.34% on August 3 indicates strong momentum, likely driven by continued digest of Q2 results and Farnborough order flow.

Investment Thesis

The core thesis rests on Boeing's ability to convert its record $715 billion backlog into sustained free cash flow while stabilizing production rates and margins. The company generated $0.6 billion in free cash flow and $1.4 billion in operating cash flow in Q2 2026, supporting liquidity of $20.0 billion in cash and investments plus $10.0 billion in undrawn credit facilities. Commercial Airplanes revenue of $11.8 billion and 171 quarterly deliveries indicate operational momentum, while the Global Services segment's 18.1% operating margin provides a profitable offset to the Commercial unit's (2.7)% margin. Management guidance targets approximately $1.5 billion in free cash flow for 2026 and a path toward exceeding $10 billion by 2028, contingent on 737 production ramping from 42 to 47 per month and certification of the 777X and 737 MAX-7/MAX-10 variants later this year.

Thesis Status

The thesis is progressing as expected but remains incomplete. The Q2 results validate the turnaround narrative through positive cash generation and record backlog, yet the company still posted a GAAP loss of ($0.67) per share and a core loss of ($0.76). The Farnborough order victory—173 aircraft versus Airbus's 154—demonstrates restored customer confidence, but the Commercial Airplanes segment remains unprofitable and the 777X program faces customer pushback, with Emirates stating it will reject the first 10 delayed jets expected in 2027. Morningstar's fair value increase to $246 implies limited upside from current levels, suggesting the stock is fairly valued within 10% of intrinsic worth. The status is cautiously on-track, with execution on production rate increases and certification timelines serving as the next critical milestones.

Key Drivers

Primary catalysts include:

• Production Ramp and Certification: Boeing is targeting 737 output of 47 per month by late 2026 and expanding to a second Everett facility, with certification of the 737 MAX-7, MAX-10, and 777X expected later this year. Morningstar; The New York Times
• Order Momentum: The company secured 173 orders at Farnborough, its first major airshow win in four years, including 100 planes from SMBC Aviation and 28 Boeing 787s for Riyadh Air. Business Insider
• Defense Segment Headwinds: A $280 million charge on the Air Force One replacement program contributed to a $15 million operating loss in Defense, Space & Security despite 13% revenue growth. Business Insider; Morningstar
• Strategic Capital Allocation: CEO Kelly Ortberg has explicitly deferred any new clean-sheet aircraft program for "a couple more years," prioritizing balance sheet repair and existing program execution over product development. CNBC; The Wall Street Journal
• Quality Improvements: Defect-related labor time on the 737 line has declined nearly 20% and fuselage defects are down 40%, supporting production stability goals. The New York Times

Technical Analysis

The stock has broken above the recent $213–$227 consolidation range with conviction, closing at $232.00. The 5-day gain of 9.69% confirms bullish short-term momentum, while the 1-day spike of 7.34% on August 3 represents a significant volume-confirmation event. YTD performance of +6.85% indicates the stock is recovering from a flat-to-negative 6-month basis. Immediate support is now established near the prior resistance zone of $226–$227, with the next psychological resistance level near $240, aligning with Morningstar's $246 fair value estimate.

Bull Case

• Record backlog of $715 billion, including over 6,200 commercial airplanes valued at $597 billion, provides multi-year revenue visibility. PR Newswire
• Positive operating cash flow of $1.4 billion and free cash flow of $0.6 billion in Q2 2026 mark a tangible inflection in cash generation, with management targeting ~$1.5 billion for the full year. PR Newswire; Morningstar
• Farnborough order victory (173 aircraft vs. Airbus's 154) signals restored airline confidence and strengthens the backlog with high-profile customers including SMBC Aviation and Riyadh Air. Business Insider
• Global Services segment delivered $5.3 billion in revenue with an 18.1% operating margin, generating $968 million in operating profit and providing stable cash flow to offset commercial losses. PR Newswire; Morningstar
• Quality metrics are improving measurably, with 737 defect-related labor time down nearly 20% and fuselage defects reduced by 40%, supporting the production rate increase to 47 per month and beyond. The New York Times

Bear Case

• The Commercial Airplanes segment remains unprofitable with a (2.7)% operating margin, and the unit is not expected to generate consistent profits in the near term due in part to a $1 billion Everett facility investment. PR Newswire; The New York Times
• Boeing posted a Q2 GAAP loss of ($0.67) per share and a core loss of ($0.76), indicating the company has not yet achieved earnings profitability despite cash flow improvement. PR Newswire
• The Commercial Airplanes segment remains unprofitable with a (2.7) percent operating margin, and management does not expect consistent profits in the near term due in part to a $1 billion investment in the Everett facility expansion. PR Newswire; The New York Times
• Defense, Space & Security posted a $15 million operating loss in Q2 despite 13% revenue growth, driven by a $280 million charge on the Air Force One replacement program, underscoring persistent defense program execution risk. Business Insider; Morningstar
• Emirates President Tim Clark stated the airline will reject the first 10 delayed 777X jets expected in 2027, creating delivery and revenue recognition risk on the flagship widebody program. Business Insider
• CEO Kelly Ortberg confirmed Boeing requires "a couple more years" to repair finances before launching a new commercial aircraft, deferring product development and ceding strategic initiative to Airbus, while the stock currently trades within 10% of Morningstar's $246 fair value estimate, limiting valuation upside. CNBC; The Wall Street Journal; Morningstar

>